[1] BRADSHAW PJ, TRAFALSKI S, HUNG J, et al.Outcomes after first percutaneous coronary intervention for acute myocardial infarction according to patient funding source[J]. BMC Health Serv Res, 2014, 14(1):1. doi: 10.1186/1472-6963-14-1
[2] MAJED AFANA MD, WALEED BRINJIKJI MD, HARRY CLOFT MD, et al.Hospitalization costs for acute myocardial infarction patients treated with percutaneous coronary intervention in the united states are substantially higher than medicare payments[J]. Clin Cardiol, 2014, 38(1):13.
[3] DURANTE A, LATIB A, PIZZETTI G, et al.A high-volume single center experience of no-reflow post-percutaneous coronary intervention[J]. G Ital Cardiol (Rome), 2014, 15(2):110.
[4] ZHANG BC, WANG C, ZHOU ZW, et al.Coronary plaque characteristics affect no-reflow during primary percutaneous coronary intervention:a pooled analysis of 14 observational studies using intravascular ultrasound[J]. Rev Cardiovasc Med, 2015, 16(3):200.
[5] 王志华, 孙仁华, 张晓晖, 等.血栓抽吸联合替罗非班对急性下壁心肌梗死的介入治疗作用[J].微循环学杂志, 2014, 24(1):40.
[6] ABDI S, RAFIZADEH O, PEIGHAMBARI M, et al.Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention[J]. Res Cardiovasc Med, 2015, 4(2):25414.
[7] QIN Q, QIAN J, FAN B, et al.Clinical outcomes after percutaneous coronary intervention in acute myocardial infarction due to unprotected left main coronary artery disease[J]. J Invasive Cardiol, 2015, 27(8):153.
[8] 巨敏, 王蕊, 张君毅, 等.Irisin水平与急性心肌梗死病人PCI术后无复流的研究[J].现代生物医学进展, 2015, 15(35):6852.
[9] WANG Z, REN L, LEI L, et al.The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.[J]. Acta Cardiologica, 2016, 71(2):241. doi: 10.1080/AC.71.2.3141856
[10] JIAO Q, KE Q, LI W, et al.Effect of inflammatory factor-induced cyclo-oxygenase expression on the development of reperfusion-related no-reflow phenomenon in acute myocardial infarction[J]. Clin Exp Pharmacol Physiol, 2015, 42(2):162. doi: 10.1111/1440-1681.12339
[11] WANG JW, ZHOU ZQ, CHEN YD, et al.A risk score for no reflow in patients with st-segment elevation myocardial infarction after primary percutaneous coronary intervention[J]. Clin Cardiol, 2015, 38(4):208. doi: 10.1002/clc.22376
[12] 成永霞, 邵芳, 周庆国, 等.冠脉内预先注入替罗非班预防急诊PCI术中无复流的研究[J].中西医结合心脑血管病杂志, 2014, 12(1):43. doi: 10.3969/j.issn.1672-1349.2014.01.0025
[13] ZHAO JL, FAN CM, YANG YJ, et al.Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients wit diabetes mellitus after primary angioplasty for acute myocardial infarction[J]. Cardiovasc Ther, 2011, 31(1):60.
[14] SCALONE G, NICCOLI G.Aspirin "resistance", diabetes mellitus and no-reflow:the elusive role of individual susceptibility in myocardial reperfusion[J]. Cardiology, 2015, 131(1):38.
[15] 付文波, 丁世芳, 陈志楠, 等.急性STEMI病人急诊PCI术中无复流影响因素分析[J].中国循证心血管医学杂志, 2014, 6(3):288. doi: 10.3969/j.1674-4055.2014.03.14
[16] 施佳, 金惠根, 欧少君, 等.预测急性心肌梗死急诊介入治疗无复流的临床和冠状动脉造影特征[J].上海医学, 2010, 33(5):430.
[17] 赵映, 陈韵岱, 田峰, 等.急性心肌梗死病人急诊PCI术后无复流的危险因素分析[J].南方医科大学学报, 2012, 32(2):261.